91. Lazar RM, Tamaroff M, Nir Y, Freund B, O'Reilly RJ, Kirkpatrick D, Kapoor, 
N: Language recovery following isolation for severe combined immunode- 
ficiency disease. Nature 1983; 306:54-55. 
92. Shank B, Chu F, Dinsmore R, Kapoor N, Kirkpatrick 0, Teitelbaum H, Reid A, 
Bonfiglio P, Simpson L, O'Reilly RJ: Hyperf ractionated total body irra- 
diation for bone marrow transplantation. Results in seventy leukemia 
patients with allogeneic transplants. Int J Radiation Oncology 1983; 
9:1607-1611. 
93. Flomenberg N, Dupont B, O'Reilly RJ, Hayward A, Pollack MS: The use of T 
cell culture techniques to establish the presence of an intrauterine- 
derived maternal T cell graft in a patient with severe combined immuno- 
deficiency (SCID). Transplantation 1983; 36:733-735. 
94. Gulati SC, Gulati C, Vega R, Gandola L, Yopp J, Dinsmore R, O'Reilly RJ, 
Clarkson B: Non-Hodgkin's lymphoma. Indian J Pediatr 1983; 50:667-674. 
95. Gulati SC, Helson L, Vega R, Gandola L, Gulati C, Yopp R, O'Reilly RJ, 
Clarkson B: Neuroblastoma. Indian J Pediatr 1983; 50:661-665. 
96. O'Reilly RJ, Kirkpatrick D, Kapoor N, Cunningham-Rundles S, Pollack MS, 
Dupont B, Hodes MZ, Collins N, Brochstein J, Reisner Y: Transplants of 
histoincompatible parental marrow depleted of T cells by differential 
agglutination with soybean lectin and E-rosette depletion for the treat- 
ment of severe combined immune deficiency. In: Griscelli C, Vossen J, 
eds: Progress in Immunodeficiency Research & Therapy I: Elsevier Science 
Publishers, 1984:385-392. 
97. Condie RM, O'Reilly RJ: Prevention of cytomegalovirus infection in bone 
marrow transplant recipients by prophylaxis with an intravenous, hyper- 
immune cytomegalovirus globulin. In: Plotkin SA, Michelson S, Pagano JS, 
Rapp F, eds: CMV: Pathogenesis and prevention of human infection. Birth 
Defects: Original Article Series, Vol 20, Alan R. Liss, Inc, New York, 
1984:327-344. Am J Med 1984; 76:134-141. 
98. Welte K, Ciobanu N, Moore MAS, Gulati S, O'Reilly RJ, Mertelsmann R: 
Defective interleukin-2 production in patients after bone marrow trans- 
plantation and in vitro restoration of defective T-lymphocyte prolifera- 
tion by highly purified interleukin-2. Blood 1984; 64:380-385. 
99. Dinsmore R, Kirkpatrick D, Flomenberg N, Gulati S, Kapoor N, Shank B, Reid 
A, Groshen S, O'Reilly RJ: Allogeneic bone marrow transplants for 
patients with acute non-lymphocytic leukemia. Blood 1984; 63:649-656. 
100. Condie RM, O'Reilly RJ: Prevention of cytomegalovirus infection by pro- 
phylaxis with an intravenous, hyperimmune, native, unmodified cytomegalo- 
virus globulin. Randomized trial in bone marrow transplant recipients. Am 
J Med 1984; 76(3A): 134-141. 
101. Mertelsmann R, Welte K, Sternberg C, O'Reilly R, Moore MAS, Clarkson BD, 
Oettgen HF : Treatment of immunodeficiency with interleukin-2: Initial 
exploration. J Biol Response Modifiers 1984; 4:483-490. 
Recombinant DNA Research, Volume 12 
1487 ] 
